Current management and clinical outcome of hemangiopericytomas

Craven, James P; Quigley, Terence M.; Bolen, John W.; Raker, Edmond J.

doi:10.1016/0002-9610(92)90394-7

Cited by 78 publications

(52 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La primera corresponde a neoplasias no HPC pero que se comportan como una, ejemplo: los sarcomas sinoviales. La segunda, a verdaderos HPC en los que hay clara evidencia de diferenciación pericítica y mioide, y la tercera a tumores fibrosos solitarios como los angiofibromas de células gigantes y hemangiopericitomas lipomatosos 7 . Siendo las extremidades inferiores la localización más común 2 , ninguno de nuestros casos la presentó.…”

Section: Discussionunclassified

Hemangiopericitoma: reporte de 3 casos

et al. 2013

Rev Chil Cir

View full text Add to dashboard Cite

Hemangiopericytoma. A report of 3 cases and a literature review Introduction: The hemangiopericytoma (HPC) is a rare vascular tumor that can be potentially malignant. It can be found in any part of the body but usually in the lower extremities or the retroperitoneum. Because its potential malign nature, it's necessary to perform oncological resections when are operating on. Methods: Three cases are presented. Results: One of them was located at the sacrococcigeal space, being the second reported case in the international literature. The other cases were in cervical and adrenal localization.

show abstract

Section: Discussionunclassified

Hemangiopericitoma: reporte de 3 casos

et al. 2013

Rev Chil Cir

View full text Add to dashboard Cite

show abstract

“…MRI and angiography are often used for evaluating hemangiopericytomas [5] . In the reported case, angiography added further information about the number and calibre of arteries feeding and veins draining the liver metastases.…”

Section: Discussionmentioning

confidence: 99%

“…Complete surgical removal is the treatment of choice for primary tumour, local recurrence and solitary metastasis [3,4] . Computed tomography (CT), magnetic resonance imaging (MRI) and angiography are classically considered the diagnostic modalities of choice for preoperative evaluation and surgical planning [5,6] . Recently, contrastenhanced MRI has emerged as a valuable non-invasive technique which provides a rich analysis of the regional vascular properties of a tumour [7,8] .…”

Section: Introductionmentioning

confidence: 99%

Hepatic metastases of hemangiopericytoma: contrast-enhanced MRI, contrast-enhanced ultrasonography and angiography findings

Aliberti¹,

Benea

Kopf

et al. 2006

Cancer Imaging

View full text Add to dashboard Cite

Hemangiopericytoma is a rare and characteristically hypervascular tumour. We report a case of hepatic metastases of hemangiopericytoma for which there was correlative imaging by ultrasonography, ultrasonography with second-generation contrast agent (BR1), computed tomography, gadolinium-enhanced, Gd-BOPTA-enhanced and ferumoxides-enhanced magnetic resonance, and angiography. To our knowledge, this is the first reported case in which all these modalities were used in the diagnostic evaluation.

show abstract

“…Surgical excision or debulking is the mainstay of treatment, and subsequent radiotherapy and/or chemotherapy following total excision may improve relapse-free survival rates compared with surgery alone (3)(4)(5). Nevertheless, the vast majority of HPCs are locally aggressive and recurrences after primary surgery are common, as more than two thirds of the cases have a propensity to develop local recurrence prior to distant metastases (2,4). We, herein, present two interesting cases: using ifosfamide as an alternative treatment modality for metastatic and recurrent HPC cases.…”

mentioning

confidence: 99%

“…Six consecutive cycles of IMEt have resulted in durable remissions in both patients. Unfortunately, there has been no consensus in the literature on the management of recurrent or metastatic HPC and the results of large series utilizing conventional therapeutic modalities do not suggest an improved overall survival (3)(4)(5)(6). Regarding the scarcity of this neoplasm, more studies are warranted to clarify the role of ifosfamide-based regimens in malignant HPC.…”

mentioning

confidence: 99%